We have compiled a list of manufacturers, distributors, product information, reference prices, and rankings for Drug development support services.
ipros is IPROS GMS ・ IPROS One of the largest technical database sites in Japan that collects information on.

Drug development support services - List of Manufacturers, Suppliers, Companies and Products | IPROS GMS

Drug development support services Product List

1~3 item / All 3 items

Displayed results

Ohsugi Biopharma Consulting Co., Ltd. Business Introduction

For consulting in pharmaceutical development, please feel free to contact us!

Ohsugi BioPharma Consulting Co., Ltd. is a company primarily engaged in pharmaceutical development support services. We provide consulting services in five areas: drug discovery research, CMC development, regenerative medicine, clinical development, and business development, with consultants who are well-versed in the fundamental research of biopharmaceuticals and the CMC development/quality assurance of both low molecular weight drugs and biopharmaceuticals/regenerative medicine products, supporting the global development of pharmaceuticals. In addition to this business, we also conduct seminar services and paper writing services. [Business Activities] ■ Pharmaceutical Development Support Services ■ Seminar Services ■ Paper Writing Services *For more details, please refer to our catalog or feel free to contact us.

  • Other Consulting Services
  • Product Development
  • Drug development support services

Added to bookmarks

Bookmarks list

Bookmark has been removed

Bookmarks list

You can't add any more bookmarks

By registering as a member, you can increase the number of bookmarks you can save and organize them with labels.

Free membership registration

Antibody drug development support service "CAMouse"

A fully human antibody mouse that ensures the normal development of B cells and directly expresses fully human IgG!

The "CAMouse" is a fully human antibody mouse that directly expresses fully human IgG while ensuring the normal development of B cells in mice. Human immunoglobulin heavy chain and K/λ light chain genes have been introduced, while simultaneously inactivating the endogenous heavy and light chain genes in the mouse. Seventy human immunoglobulin V regions, including 32 VH, 22 VK, and 16 Vλ, have been incorporated, providing a rich diversity of rearrangement. [Technological Advantages] ■ Establishment of efficient transgenic technology for ultra-large genes (>500kb) ■ Development of technology to spatially and temporally control B cell development in the host animal, allowing for the production of fully human IgG all at once. *For more details, please download the PDF or feel free to contact us.

  • others
  • Drug development support services

Added to bookmarks

Bookmarks list

Bookmark has been removed

Bookmarks list

You can't add any more bookmarks

By registering as a member, you can increase the number of bookmarks you can save and organize them with labels.

Free membership registration